Sight Sciences to Report Third Quarter 2021 Financial Results on November 10, 2021
October 27, 2021 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) today announced it will report financial results for the quarter ended September 30, 2021 after the market...
Sight Sciences Announces TearCare® Clinical Data Published in Cornea
October 20, 2021 08:00 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused on addressing the underlying causes of the world's most...
Sight Sciences Files Lawsuit Against Ivantis for Patent Infringement
September 16, 2021 18:29 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ: SGHT) today announced that it filed a lawsuit in the United States District Court in Delaware against Ivantis,...
Sight Sciences to Participate in the Morgan Stanley Global Healthcare Conference
August 26, 2021 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused on developing and commercializing devices designed to address...
Sight Sciences, Pioneering the Development of the Standalone MIGS Market, Announces Publication of Favorable Two-Year Outcomes of Standalone Use of the OMNI® Surgical System in Mild to Moderate Open-Angle Glaucoma
August 24, 2021 08:00 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused on developing and commercializing devices designed to address...
Sight Sciences Reports Second Quarter 2021 Financial Results
August 12, 2021 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of...
Sight Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021
August 02, 2021 16:34 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) today announced it will report financial results for the second quarter 2021 after the market close on...
Sight Sciences Announces Multiple Presentations at the 2021 American Society of Cataract and Refractive Surgery Annual Meeting
July 22, 2021 20:14 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused on addressing the underlying causes of the world's most...
Sight Sciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
July 19, 2021 17:22 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc., a growth-stage medical device company focused on the development and commercialization of proprietary devices that target...
Sight Sciences Announces Pricing of Initial Public Offering
July 14, 2021 18:53 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc., a growth-stage medical device company focused on the development and commercialization of proprietary devises that target...